1 Study Coverage 1.1 Anti-inflammatory Drugs Product Introduction 1.2 Market Segments 1.3 Key Anti-inflammatory Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type 1.4.2 Aspirin 1.4.3 Ibuprofen 1.4.4 Naproxen 1.4.5 Celecoxib 1.4.6 Others 1.5 Market by Application 1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application 1.5.2 Skin Rashes 1.5.3 Chronic Arthritis 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Anti-inflammatory Drugs Market Size, Estimates and Forecasts 2.1.1 Global Anti-inflammatory Drugs Revenue 2015-2026 2.1.2 Global Anti-inflammatory Drugs Sales 2015-2026 2.2 Global Anti-inflammatory Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Anti-inflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Anti-inflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Anti-inflammatory Drugs Competitor Landscape by Players 3.1 Anti-inflammatory Drugs Sales by Manufacturers 3.1.1 Anti-inflammatory Drugs Sales by Manufacturers (2015-2020) 3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Anti-inflammatory Drugs Revenue by Manufacturers 3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Anti-inflammatory Drugs Revenue in 2019 3.2.5 Global Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Anti-inflammatory Drugs Price by Manufacturers 3.4 Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types 3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Anti-inflammatory Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Anti-inflammatory Drugs Market Size by Type (2015-2020) 4.1.1 Global Anti-inflammatory Drugs Sales by Type (2015-2020) 4.1.2 Global Anti-inflammatory Drugs Revenue by Type (2015-2020) 4.1.3 Anti-inflammatory Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Anti-inflammatory Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Anti-inflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Anti-inflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Anti-inflammatory Drugs Market Size by Application (2015-2020) 5.1.1 Global Anti-inflammatory Drugs Sales by Application (2015-2020) 5.1.2 Global Anti-inflammatory Drugs Revenue by Application (2015-2020) 5.1.3 Anti-inflammatory Drugs Price by Application (2015-2020) 5.2 Anti-inflammatory Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Anti-inflammatory Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Anti-inflammatory Drugs by Country 6.1.1 North America Anti-inflammatory Drugs Sales by Country 6.1.2 North America Anti-inflammatory Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Anti-inflammatory Drugs Market Facts & Figures by Type 6.3 North America Anti-inflammatory Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Anti-inflammatory Drugs by Country 7.1.1 Europe Anti-inflammatory Drugs Sales by Country 7.1.2 Europe Anti-inflammatory Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Anti-inflammatory Drugs Market Facts & Figures by Type 7.3 Europe Anti-inflammatory Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Anti-inflammatory Drugs by Region 8.1.1 Asia Pacific Anti-inflammatory Drugs Sales by Region 8.1.2 Asia Pacific Anti-inflammatory Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Type 8.3 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Anti-inflammatory Drugs by Country 9.1.1 Latin America Anti-inflammatory Drugs Sales by Country 9.1.2 Latin America Anti-inflammatory Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Type 9.3 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Anti-inflammatory Drugs by Country 10.1.1 Middle East and Africa Anti-inflammatory Drugs Sales by Country 10.1.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Description and Business Overview 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Roche Anti-inflammatory Drugs Products Offered 11.1.5 Roche Related Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Corporation Information 11.2.2 Abbott Laboratories Description and Business Overview 11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Abbott Laboratories Anti-inflammatory Drugs Products Offered 11.2.5 Abbott Laboratories Related Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Corporation Information 11.3.2 Johnson & Johnson Description and Business Overview 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Johnson & Johnson Anti-inflammatory Drugs Products Offered 11.3.5 Johnson & Johnson Related Developments 11.4 Merck & Co. 11.4.1 Merck & Co. Corporation Information 11.4.2 Merck & Co. Description and Business Overview 11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Merck & Co. Anti-inflammatory Drugs Products Offered 11.4.5 Merck & Co. Related Developments 11.5 Pfizer 11.5.1 Pfizer Corporation Information 11.5.2 Pfizer Description and Business Overview 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Pfizer Anti-inflammatory Drugs Products Offered 11.5.5 Pfizer Related Developments 11.6 Amgen 11.6.1 Amgen Corporation Information 11.6.2 Amgen Description and Business Overview 11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Amgen Anti-inflammatory Drugs Products Offered 11.6.5 Amgen Related Developments 11.7 Sanofi 11.7.1 Sanofi Corporation Information 11.7.2 Sanofi Description and Business Overview 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Sanofi Anti-inflammatory Drugs Products Offered 11.7.5 Sanofi Related Developments 11.8 Novartis 11.8.1 Novartis Corporation Information 11.8.2 Novartis Description and Business Overview 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Novartis Anti-inflammatory Drugs Products Offered 11.8.5 Novartis Related Developments 11.9 Eli Lilly 11.9.1 Eli Lilly Corporation Information 11.9.2 Eli Lilly Description and Business Overview 11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Eli Lilly Anti-inflammatory Drugs Products Offered 11.9.5 Eli Lilly Related Developments 11.10 Amgen 11.10.1 Amgen Corporation Information 11.10.2 Amgen Description and Business Overview 11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Amgen Anti-inflammatory Drugs Products Offered 11.10.5 Amgen Related Developments 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Description and Business Overview 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Roche Anti-inflammatory Drugs Products Offered 11.1.5 Roche Related Developments 11.12 Novacap 11.12.1 Novacap Corporation Information 11.12.2 Novacap Description and Business Overview 11.12.3 Novacap Sales, Revenue and Gross Margin (2015-2020) 11.12.4 Novacap Products Offered 11.12.5 Novacap Related Developments 11.13 Kopran Ltd. 11.13.1 Kopran Ltd. Corporation Information 11.13.2 Kopran Ltd. Description and Business Overview 11.13.3 Kopran Ltd. Sales, Revenue and Gross Margin (2015-2020) 11.13.4 Kopran Ltd. Products Offered 11.13.5 Kopran Ltd. Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Anti-inflammatory Drugs Market Estimates and Projections by Region 12.1.1 Global Anti-inflammatory Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Anti-inflammatory Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Anti-inflammatory Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Anti-inflammatory Drugs Sales Forecast (2021-2026) 12.2.2 North America: Anti-inflammatory Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Anti-inflammatory Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Anti-inflammatory Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Anti-inflammatory Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Anti-inflammatory Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Anti-inflammatory Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Anti-inflammatory Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Anti-inflammatory Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Anti-inflammatory Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Anti-inflammatory Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Anti-inflammatory Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Anti-inflammatory Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Anti-inflammatory Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Anti-inflammatory Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Anti-inflammatory Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Anti-inflammatory Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Anti-inflammatory Drugs Market Segments Table 2. Ranking of Global Top Anti-inflammatory Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Anti-inflammatory Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Aspirin Table 5. Major Manufacturers of Ibuprofen Table 6. Major Manufacturers of Naproxen Table 7. Major Manufacturers of Celecoxib Table 8. Major Manufacturers of Others Table 9. Global Anti-inflammatory Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 10. Global Anti-inflammatory Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 11. Global Anti-inflammatory Drugs Sales by Regions 2015-2020 (K Units) Table 12. Global Anti-inflammatory Drugs Sales Market Share by Regions (2015-2020) Table 13. Global Anti-inflammatory Drugs Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Anti-inflammatory Drugs Sales by Manufacturers (2015-2020) (K Units) Table 15. Global Anti-inflammatory Drugs Sales Share by Manufacturers (2015-2020) Table 16. Global Anti-inflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 17. Global Anti-inflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Drugs as of 2019) Table 18. Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 19. Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020) Table 20. Key Manufacturers Anti-inflammatory Drugs Price (2015-2020) (USD/Unit) Table 21. Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Anti-inflammatory Drugs Product Type Table 23. Date of International Manufacturers Enter into Anti-inflammatory Drugs Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 26. Global Anti-inflammatory Drugs Sales Share by Type (2015-2020) Table 27. Global Anti-inflammatory Drugs Revenue by Type (2015-2020) (US$ Million) Table 28. Global Anti-inflammatory Drugs Revenue Share by Type (2015-2020) Table 29. Anti-inflammatory Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 30. Global Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 31. Global Anti-inflammatory Drugs Sales Share by Application (2015-2020) Table 32. North America Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units) Table 33. North America Anti-inflammatory Drugs Sales Market Share by Country (2015-2020) Table 34. North America Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. North America Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020) Table 36. North America Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 37. North America Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Table 38. North America Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 39. North America Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Table 40. Europe Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units) Table 41. Europe Anti-inflammatory Drugs Sales Market Share by Country (2015-2020) Table 42. Europe Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million) Table 43. Europe Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020) Table 44. Europe Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 45. Europe Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Table 46. Europe Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 47. Europe Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Table 48. Asia Pacific Anti-inflammatory Drugs Sales by Region (2015-2020) (K Units) Table 49. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Region (2015-2020) Table 50. Asia Pacific Anti-inflammatory Drugs Revenue by Region (2015-2020) (US$ Million) Table 51. Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Region (2015-2020) Table 52. Asia Pacific Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 53. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Table 54. Asia Pacific Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 55. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Table 56. Latin America Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units) Table 57. Latin America Anti-inflammatory Drugs Sales Market Share by Country (2015-2020) Table 58. Latin Americaa Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million) Table 59. Latin America Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020) Table 60. Latin America Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 61. Latin America Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Table 62. Latin America Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 63. Latin America Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Table 64. Middle East and Africa Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units) Table 65. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Country (2015-2020) Table 66. Middle East and Africa Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million) Table 67. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020) Table 68. Middle East and Africa Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units) Table 69. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Table 70. Middle East and Africa Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units) Table 71. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Table 72. Roche Corporation Information Table 73. Roche Description and Major Businesses Table 74. Roche Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 75. Roche Product Table 76. Roche Recent Development Table 77. Abbott Laboratories Corporation Information Table 78. Abbott Laboratories Description and Major Businesses Table 79. Abbott Laboratories Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 80. Abbott Laboratories Product Table 81. Abbott Laboratories Recent Development Table 82. Johnson & Johnson Corporation Information Table 83. Johnson & Johnson Description and Major Businesses Table 84. Johnson & Johnson Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 85. Johnson & Johnson Product Table 86. Johnson & Johnson Recent Development Table 87. Merck & Co. Corporation Information Table 88. Merck & Co. Description and Major Businesses Table 89. Merck & Co. Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 90. Merck & Co. Product Table 91. Merck & Co. Recent Development Table 92. Pfizer Corporation Information Table 93. Pfizer Description and Major Businesses Table 94. Pfizer Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 95. Pfizer Product Table 96. Pfizer Recent Development Table 97. Amgen Corporation Information Table 98. Amgen Description and Major Businesses Table 99. Amgen Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 100. Amgen Product Table 101. Amgen Recent Development Table 102. Sanofi Corporation Information Table 103. Sanofi Description and Major Businesses Table 104. Sanofi Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 105. Sanofi Product Table 106. Sanofi Recent Development Table 107. Novartis Corporation Information Table 108. Novartis Description and Major Businesses Table 109. Novartis Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 110. Novartis Product Table 111. Novartis Recent Development Table 112. Eli Lilly Corporation Information Table 113. Eli Lilly Description and Major Businesses Table 114. Eli Lilly Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 115. Eli Lilly Product Table 116. Eli Lilly Recent Development Table 117. Amgen Corporation Information Table 118. Amgen Description and Major Businesses Table 119. Amgen Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 120. Amgen Product Table 121. Amgen Recent Development Table 122. Bayer Corporation Information Table 123. Bayer Description and Major Businesses Table 124. Bayer Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 125. Bayer Product Table 126. Bayer Recent Development Table 127. Novacap Corporation Information Table 128. Novacap Description and Major Businesses Table 129. Novacap Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 130. Novacap Product Table 131. Novacap Recent Development Table 132. Kopran Ltd. Corporation Information Table 133. Kopran Ltd. Description and Major Businesses Table 134. Kopran Ltd. Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 135. Kopran Ltd. Product Table 136. Kopran Ltd. Recent Development Table 137. Global Anti-inflammatory Drugs Sales Forecast by Regions (2021-2026) (K Units) Table 138. Global Anti-inflammatory Drugs Sales Market Share Forecast by Regions (2021-2026) Table 139. Global Anti-inflammatory Drugs Revenue Forecast by Regions (2021-2026) (US$ Million) Table 140. Global Anti-inflammatory Drugs Revenue Market Share Forecast by Regions (2021-2026) Table 141. North America: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 142. North America: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 143. Europe: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 144. Europe: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 145. Asia Pacific: Anti-inflammatory Drugs Sales Forecast by Region (2021-2026) (K Units) Table 146. Asia Pacific: Anti-inflammatory Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 147. Latin America: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 148. Latin America: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 149. Middle East and Africa: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units) Table 150. Middle East and Africa: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million) Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 152. Key Challenges Table 153. Market Risks Table 154. Main Points Interviewed from Key Anti-inflammatory Drugs Players Table 155. Anti-inflammatory Drugs Customers List Table 156. Anti-inflammatory Drugs Distributors List Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Anti-inflammatory Drugs Product Picture Figure 2. Global Anti-inflammatory Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Aspirin Product Picture Figure 4. Ibuprofen Product Picture Figure 5. Naproxen Product Picture Figure 6. Celecoxib Product Picture Figure 7. Others Product Picture Figure 8. Global Anti-inflammatory Drugs Sales Market Share by Application in 2020 & 2026 Figure 9. Skin Rashes Figure 10. Chronic Arthritis Figure 11. Other Figure 12. Anti-inflammatory Drugs Report Years Considered Figure 13. Global Anti-inflammatory Drugs Market Size 2015-2026 (US$ Million) Figure 14. Global Anti-inflammatory Drugs Sales 2015-2026 (K Units) Figure 15. Global Anti-inflammatory Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 16. Global Anti-inflammatory Drugs Sales Market Share by Region (2015-2020) Figure 17. Global Anti-inflammatory Drugs Sales Market Share by Region in 2019 Figure 18. Global Anti-inflammatory Drugs Revenue Market Share by Region (2015-2020) Figure 19. Global Anti-inflammatory Drugs Revenue Market Share by Region in 2019 Figure 20. Global Anti-inflammatory Drugs Sales Share by Manufacturer in 2019 Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Drugs Revenue in 2019 Figure 22. Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 23. Global Anti-inflammatory Drugs Sales Market Share by Type (2015-2020) Figure 24. Global Anti-inflammatory Drugs Sales Market Share by Type in 2019 Figure 25. Global Anti-inflammatory Drugs Revenue Market Share by Type (2015-2020) Figure 26. Global Anti-inflammatory Drugs Revenue Market Share by Type in 2019 Figure 27. Global Anti-inflammatory Drugs Market Share by Price Range (2015-2020) Figure 28. Global Anti-inflammatory Drugs Sales Market Share by Application (2015-2020) Figure 29. Global Anti-inflammatory Drugs Sales Market Share by Application in 2019 Figure 30. Global Anti-inflammatory Drugs Revenue Market Share by Application (2015-2020) Figure 31. Global Anti-inflammatory Drugs Revenue Market Share by Application in 2019 Figure 32. North America Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 33. North America Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 34. North America Anti-inflammatory Drugs Sales Market Share by Country in 2019 Figure 35. North America Anti-inflammatory Drugs Revenue Market Share by Country in 2019 Figure 36. U.S. Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 37. U.S. Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Canada Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 39. Canada Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. North America Anti-inflammatory Drugs Market Share by Type in 2019 Figure 41. North America Anti-inflammatory Drugs Market Share by Application in 2019 Figure 42. Europe Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 43. Europe Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 44. Europe Anti-inflammatory Drugs Sales Market Share by Country in 2019 Figure 45. Europe Anti-inflammatory Drugs Revenue Market Share by Country in 2019 Figure 46. Germany Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 47. Germany Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. France Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 49. France Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. U.K. Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 51. U.K. Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Italy Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 53. Italy Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Russia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 55. Russia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Europe Anti-inflammatory Drugs Market Share by Type in 2019 Figure 57. Europe Anti-inflammatory Drugs Market Share by Application in 2019 Figure 58. Asia Pacific Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 59. Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 60. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Region in 2019 Figure 61. Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Region in 2019 Figure 62. China Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 63. China Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Japan Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 65. Japan Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. South Korea Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 67. South Korea Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. India Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 69. India Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Australia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 71. Australia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Taiwan Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 73. Taiwan Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Indonesia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 75. Indonesia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Thailand Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 77. Thailand Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Malaysia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 79. Malaysia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Philippines Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 81. Philippines Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Vietnam Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 83. Vietnam Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Asia Pacific Anti-inflammatory Drugs Market Share by Type in 2019 Figure 85. Asia Pacific Anti-inflammatory Drugs Market Share by Application in 2019 Figure 86. Latin America Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 87. Latin America Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 88. Latin America Anti-inflammatory Drugs Sales Market Share by Country in 2019 Figure 89. Latin America Anti-inflammatory Drugs Revenue Market Share by Country in 2019 Figure 90. Mexico Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 91. Mexico Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Brazil Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 93. Brazil Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Argentina Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 95. Argentina Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Latin America Anti-inflammatory Drugs Market Share by Type in 2019 Figure 97. Latin America Anti-inflammatory Drugs Market Share by Application in 2019 Figure 98. Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units) Figure 99. Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 100. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Country in 2019 Figure 101. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Country in 2019 Figure 102. Turkey Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 103. Turkey Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Saudi Arabia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 105. Saudi Arabia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. U.A.E Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units) Figure 107. U.A.E Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. Middle East and Africa Anti-inflammatory Drugs Market Share by Type in 2019 Figure 109. Middle East and Africa Anti-inflammatory Drugs Market Share by Application in 2019 Figure 110. North America Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 111. North America Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Europe Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. Europe Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Asia Pacific Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Latin America Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Latin America Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Porter's Five Forces Analysis Figure 121. Channels of Distribution Figure 122. Distributors Profiles Figure 123. Bottom-up and Top-down Approaches for This Report Figure 124. Data Triangulation Figure 125. Key Executives Interviewed